Cell therapy and regenerative medicine. Glossary Ingestion-build-86103 3 of the PMP)

3 of the PMP)

5 Trimming marks

BS EN 1994-1-1 is for direct application

BS EN 61000-4-4:2012 supersedes BS EN 61000-4-4:2004+A1:2010 which is withdrawn

Managers responsible for risk

Cell therapy and regenerative medicine. Glossary Ingestion-build-86103 3 of the PMP)1 Scope This PAS lists terms and definitions: a) associated with the naming of types of cell therapy and regenerative medicine products; and b) that describe materials, processes, methodologies and applications within cell therapies and regenerative medicine. It covers: i) general terms; ii) cell and tissue components; iii) non cellular components; iv) cell and tissue procurement; v) measurement and analysis; vi) manufacturing and production; and vii)